1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Massachusetts >
  6. MEI Pharma Acquires Infinity Pharmaceuticals

M&A Deal Summary

MEI Pharma Acquires Infinity Pharmaceuticals

On February 23, 2023, MEI Pharma acquired life science company Infinity Pharmaceuticals

Acquisition Highlights
  • This is MEI Pharma’s 1st transaction in the Life Science sector.
  • This is MEI Pharma’s 1st transaction in the United States.
  • This is MEI Pharma’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2023-02-23
Target Infinity Pharmaceuticals
Sector Life Science
Buyer(s) MEI Pharma
Deal Type Merger
Advisor(s) Aquilo Partners (Financial)
Wilmer Cutler Pickering Hale and Dorr (Legal)

Target

Infinity Pharmaceuticals

Cambridge, Massachusetts, United States
Infinity Pharmaceuticals is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which is designed to address a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies. Infinity Pharmaceuticals is based in Cambridge, Massachusetts.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MEI Pharma

San Diego, California, United States
Category Company
Founded 2000
Sector Life Science
Employees28
Revenue 65M USD (2024)
DESCRIPTION

MEI Pharma is a pharmaceutical company focused on developing potential new therapies for cancer. The company's portfolio of drug candidates includes clinical-stage candidates with differentiated mechanisms of action intended to address unmet medical needs and deliver improved benefits to patients, either as standalone treatments or in combination with other therapeutic options. MEI Pharma was founded in 2000 and is based in San Diego, California.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal